BioCentury This Week
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.
For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
- Update frequency
- every 5 days
- Average duration
- 24 minutes
- Episodes
- 330
- Years Active
- 2020 - 2025
Ep. 5 - Master Protocols, EUAs and Rick Bright: BioCentury editors on COVID-19
Ep. 4 - End of the beginning for vaccines and the post-pandemic future
BioCentury editors discuss Goldilocks COVID-19 antibody test regulation, vaccine development, and the post-pandemic future.
Ep. 3 - Surveying the Landscape for Biopharmas
BioCentury Editors discuss what the latest survey results tell us about how biotechs are managing through the economic downturn, and cover what FDA Commissioner Hahn told BioCentury last week.
Ep. 2 - Consorting to beat COVID-19
How industry, government and academics are joining together to discover, develop and deploy therapies and vaccines.
Ep. 1 - Racing to Create Countermeasures
It has been three months since Chinese scientists revealed the genomic sequence of SARS-CoV-2. In our first episode, “Racing to Create Countermeasures,” BioCentury’s editors discuss progress made by …